Oncology

PCNSL

Advertisement

Conference Reporter® in Primary Central Nervous System Lymphoma to Cover Key Topics Being Presented at the 2025 American Society of Hematology Annual Meeting

conference reporter by Christopher R. D’Angelo, MD; Matthias Holdhoff, MD, PhD
Overview

Conference Reporter delivers health care providers with insights from key thought leaders on exciting news presented at major medical conferences, in a concise and timely format. Conference Reporter will feature community-selected experts and topics in Primary Central Nervous System Lymphoma presented at the 2025 American Society of Hematology Annual Meeting.

 


 

VIEW THE TOPICS

  • Novel Therapies and Drugs in Development for Primary Central Nervous System Lymphoma
  • Overview of Treatment Options and Adverse Effects for Primary Central Nervous System Lymphoma
  • Personalized Treatment for Primary Central Nervous System Lymphoma
  • Treatment Goals and Outcomes of Primary Central Nervous System Lymphoma

 

This information is brought to you by Engage Health Media and is not sponsored, endorsed, or accredited by the American Society of Hematology.

 

67th ASH Annual Meeting and Exposition

December 6-9, 2025

Orlando, Florida

Registration Link

Christopher R. D’Angelo, MD

Assistant Professor
Division of Hematology and Oncology
Department of Internal Medicine
University of Nebraska Medical Center
Omaha, NE

Matthias Holdhoff, MD, PhD

Co-Director, Brain Cancer Disease Group
Professor of Oncology, Neurology, and Neurological Surgery
Sidney Kimmel Comprehensive Cancer Center
Johns Hopkins University School of Medicine
Baltimore, MD

Advertisement